Multiple Sclerosis Study

Study Purpose: To evaluate the efficacy of study medication in reducing the frequency of relapses compared to placebo in patients with RRMS treated for up to 24 months.

Basic Eligibility Criteria:

• Patients between 18 and 55 years old
• Relapsing-remitting course with at least 1 documented relapse during the previous year or 2 documented relapses during the previous 2 years

Multiple Sclerosis Study

Study Purpose: To test the safety and tolerability of study drug in patients with a relapsing form of Multiple Sclerosis.

Basic Eligibility Criteria:

• Patients between 18 and 55 years old
• Diagnosis of a relapsing form of MS
• Not currently taking any MS medications

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Angelo Termine, Clinical Research Manager, at atermine@anscneuro.com

Amanda Herrera, Clinical Research Administrative Assistant, at aherrera@anscneuro.com 

or any of our Clinical Research Coordinators: 

Sharon Kingson at skingson@anscneuro.com

Elizabeth Perrotti at eperrotti@anscneuro.com

Grace Castaneda at gcastaneda@anscneuro.com 

Cindy Chu at cchu@anscneuro.com or

Amanda Lemieux at alemieux@anscneuro.com

You may also call 203.333.1151 and we will be happy to answer any of your questions.